Nanoviricides Inc
(NNVC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 06-2020 | 06-2019 | 06-2018 | 06-2017 | 06-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -13,447 | -8,424 | -8,564 | -10,305 | -10,725 |
| Depreciation Amortization | 721 | 696 | 1,039 | 2,011 | 2,087 |
| Accounts payable and accrued liabilities | 111 | 803 | -146 | -388 | 458 |
| Other Working Capital | 120 | 568 | 32 | -486 | 337 |
| Other Operating Activity | 5,830 | -445 | -138 | 1,270 | 1,014 |
| Operating Cash Flow | $-6,666 | $-6,803 | $-7,776 | $-7,898 | $-6,829 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -9 | -74 | -242 | -165 | -476 |
| Investing Cash Flow | $-9 | $-74 | $-242 | $-165 | $-476 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 1,255 | N/A | N/A | N/A | N/A |
| Debt Repayment | N/A | N/A | N/A | -1,000 | N/A |
| Common Stock Issued | 16,677 | 2,350 | N/A | N/A | N/A |
| Other Financing Activity | -105 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $17,828 | $2,350 | $N/A | $-1,000 | $N/A |
| Beginning Cash Position | 2,555 | 7,082 | 15,100 | 24,162 | 31,468 |
| End Cash Position | 13,709 | 2,555 | 7,082 | 15,100 | 24,162 |
| Net Cash Flow | $11,153 | $-4,527 | $-8,018 | $-9,063 | $-7,306 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,666 | -6,803 | -7,776 | -7,898 | -6,829 |
| Capital Expenditure | -9 | -74 | -242 | -165 | -476 |
| Free Cash Flow | -6,674 | -6,877 | -8,018 | -8,063 | -7,306 |